American well chief product & tech. officer sells $109,746 in stock

Dmitry Zamansky, Chief Product & Technology Officer at American Well Corp (NASDAQ:AMWL), sold 8,442 shares of the company’s Class A Common Stock on October 1, 2026.

The transactions totaled $109,746, with shares sold at a price of $13 each. These sales were made to cover tax liabilities arising from the vesting and settlement of restricted stock units and were executed through an automatic "sell to cover" transaction, not a discretionary trade by Mr. Zamansky. Following these transactions, Mr. Zamansky directly holds 224,178 shares of American Well Corp Class A Common Stock.The sale comes as AMWL shares trade at $12.70, near their 52-week high of $14.19, following a remarkable 159% year-to-date surge. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment. Investors seeking deeper insights can access comprehensive Pro Research Reports and 10+ additional ProTips for AMWL on the platform.

In other recent news, American Well Corp., also known as Amwell, reported second-quarter 2026 results that surpassed Wall Street expectations in both earnings and revenue. The company posted an adjusted loss per share of $0.59, which was narrower than the anticipated $0.89 loss, and reported revenue of $52.05 million, exceeding the forecasted $50.10 million. Following these results, Amwell raised its full-year outlook. Truist Securities has adjusted its price target for Amwell, increasing it from $7.50 to $12.00, while maintaining a Hold rating. This adjustment is based on the firm’s updated estimates for the company’s future EBITDA. Truist now projects Amwell’s revenue to reach $203 million in FY26 and $207 million in FY27, slightly higher than previous estimates. These developments reflect a more positive outlook for the telehealth company.